ClinicalTrials.gov
public full text
Public Domain
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
This is a phase II double blind, placebo-controlled, randomized study of Artesunate suppositories for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Short-Term Outcome of Medical Vs. Surgical Management Of Chronic Anal Fissure#838062
- Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding#860888
- Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults#845550
- Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding#1048001
- Pharmacokinetics Trial of Isosorbide Mononitrate 0.5% Gel for Intra Anal Application in Healthy Subjects#890828
Record · ID 1128127
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive